56 min listen
Unavailable
ratings:
Length:
71 minutes
Released:
Apr 16, 2018
Format:
Podcast episode
Description
Ingmar Gorman, PhD, clinical psychologist and principal investigator in MAPS’ research into MDMA-assisted psychotherapy, is our guest this week. Ingmar shares with us his journey into the world of psychedelic therapy, and what he hopes the research at MAPS can achieve. We also discuss the rise of microdosing, and why Ingmar believes we should be cautious about its benefits. For show links: https://thethirdwave.co/podcast/episode-47-ingmar-gorman/ Sign up to our microdosing course! https://thethirdwave.co/microdosing-course/
Released:
Apr 16, 2018
Format:
Podcast episode
Titles in the series (100)
Dr. Molly Maloof, M.D - Neuroplasticity, Psychedelics, and Other Strategies for Boosting Immunity: Dr. Molly Maloof—physician, nutritional consultant, and popular speaker—chats with Paul Austin on how to boost our immunity and foster neuroplasticity through psychedelics, meditation, and healthier lifestyle choices. Tune in to discover some... by The Psychedelic Podcast